🔴 Oncolytics Biotech is trading 6.3% down with no confirmed catalyst

Oncolytics Biotech is trading 6.32% down at $0.51, with no verified explanation identified for the October 16 decline.

• No verified company-specific announcement or reliable report directly explaining the decline was found.
• The latest company news located was the October 14 GOBLET study and grant-payment update.
• Biotech was rising, while broader market figures were mixed and did not establish a clear cause.